Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

462.88 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4
Open 462.88
Bid (Size) 454.79 (1)
Ask (Size) 469.99 (1)
Prev. Close 462.88
Today's Range 462.88 - 462.88
52wk Range 341.85 - 510.63
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following patient deaths. 
Via Investor's Business Daily
Vertex Highlights First Oral Presentation of Phase 3 Clinical Data of the Vanza Triple and New Data on Long-Term Impact of TRIKAFTA® at the North American Cystic Fibrosis Conference
From Vertex Pharmaceuticals Incorporated
Via Business Wire

Performance

YTD
+12.65%
+12.65%
1 Month
-6.66%
-6.66%
3 Month
-1.78%
-1.78%
6 Month
+10.08%
+10.08%
1 Year
+33.05%
+33.05%

More News

Read More
If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,200 Today
Via Benzinga
The Best Biotech Stock to Invest $1,000 in Right Now
Via The Motley Fool
Demystifying Vertex Pharmaceuticals: Insights From 16 Analyst Reviews
Via Benzinga
Looking Into Vertex Pharmaceuticals's Recent Short Interest
Via Benzinga
Vertex Pharmaceuticals's Options Frenzy: What You Need to Know
Via Benzinga
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Via The Motley Fool
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
Via The Motley Fool
3 Stocks to Buy and Hold Forever
Via The Motley Fool
Prediction: These 3 Phenomenal Stocks Are Set to Soar
Via The Motley Fool
Time To Invest And Or Trade In Bio-Tech Stocks?
Via Talk Markets
Topics ETFs
Looking Into Vertex Pharmaceuticals's Recent Short Interest
Via Benzinga
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today
Via Benzinga
Biotech Breakout: Stocks for Your Watchlist
Via MarketBeat
Topics ETFs
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years
Via Benzinga
3 No-Brainer Stocks to Buy in September
Via The Motley Fool
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
Via The Motley Fool
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
Via The Motley Fool
Biotech And Life Science Sector Update Summer Of 2024
Via Talk Markets
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
Via Benzinga
Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead
Via The Motley Fool
Vertex to Participate in Upcoming September Investor Conferences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Biotech Bull Market: 3 Ways To Play It
Via Talk Markets
Topics Economy
Exposures Interest Rates
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.